Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00159965 · ClinicalTrials.gov registry record · Phase 4
Treatments for Psychogenic Nonepileptic Seizures (NES)
A Phase 4 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT00159965 is a Phase 4 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 38 participants.
The verdict
NCT00159965, a Phase 4 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
The investigators propose that treatment of the comorbid disorders (depression, anxiety, and impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES), will result in a decreased number of NES. The purpose of this study is to provide pilot testing and data to inform the future randomized controlled trial based on the hypothesis.
Interventions
- DRUG placebo
- DRUG sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2003-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00159965
The ClinicalTrials.gov registry entry for NCT00159965 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00159965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00159965 about?
NCT00159965 is a clinical study titled "Treatments for Psychogenic Nonepileptic Seizures (NES)". The investigators propose that treatment of the comorbid disorders (depression, anxiety, and impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES), will result in a decreased number of NES. The purpose of this study is to provide pilot testing and data to inform ...
What is the current status of trial NCT00159965?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2003-12. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00159965?
The interventions under investigation include: placebo (DRUG), sertraline (DRUG).
Who is sponsoring clinical trial NCT00159965?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.